InfuSystem Holdings (INFU) Cost of Revenue (2010 - 2026)

InfuSystem Holdings has reported Cost of Revenue for 17 years, with the latest figure at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 80.19% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $37.3 million (down 26.8% YoY), and the FY2025 full-year result was $10.5 million, down 83.73% from the prior year.
• Cost of Revenue for Q1 2026 stood at $3.1 million, up from $2.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $17.0 million in Q2 2024, with the low at -$35.0 million in Q4 2023.
• Historically, Cost of Revenue has averaged $5.8 million across 5 years, with a median of $11.1 million in 2022.
• Annual changes were most pronounced in 2022 — Cost of Revenue tumbled 894.1% — and 2025, when it jumped 468.71%.
• InfuSystem Holdings' Cost of Revenue stood at -$22.3 million in 2022, then sank by 56.51% to -$35.0 million in 2023, then soared by 144.71% to $15.6 million in 2024, then tumbled by 84.44% to $2.4 million in 2025, then gained by 26.64% to $3.1 million in 2026.
• The last three Cost of Revenue figures came in at $3.1 million (Q1 2026), $2.4 million (Q4 2025), and $15.7 million (Q3 2025), per Business Quant data.